Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCardinal Health Inc

Cardinal Health Inc

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
261.93 USD 8.99 ( 3.55%)
Last update at 2026-11-04T21:00:00Z
VOLUME
2420745
Market Cap
48220.96M
P/E
29.48

Momentum Score

…

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
251.74
Low
262.22
High
52 Week Price Range
131.99
Low
233.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cardinal Health Inc. distributes pharmaceuticals, medical and surgical products and provides pharmacy and supply-chain services to hospitals, pharmacies and manufacturers. Long-term growth drivers include aging populations, rising specialty drug volumes, expansion of outpatient and surgical care, and adoption of supply-chain automation. Its scale and recurring distribution contracts may support relatively stable, defensive cash flows.

The business faces material risks from pricing competition and contract loss, margin pressure and reimbursement shifts, significant regulatory and legal exposure including opioid-related litigation, and supply-chain disruptions that could reduce earnings.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
252.94
Dividend Yield
0.97%
Revenue TTM
244673.00M
Revenue Per Share
1025.88
Gross Profit TTM
9041.00M
Debt / Equity
-3.36
ROE
-
Net Debt
5471.00M
ROCE
16.28%
Diluted EPS TTM
6.95

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 2101.00M 1201.00M 638.00M -769.00M 323.00M
Minority interest -8.00M -1.00M -1.00M 1.00M 3.00M
Net income 1561.00M 852.00M 261.00M -932.00M 611.00M
Selling general administrative 5382.00M 5000.00M 4834.00M 4557.00M 4533.00M
Selling and marketing expenses 5382.00M 5000.00M 4834.00M 4557.00M 4533.00M
Gross profit 8168.00M 7414.00M 6889.00M 6545.00M 6778.00M
Reconciled depreciation 790.00M 710.00M 692.00M 692.00M 783.00M
Ebit 2316.00M 1252.00M 1774.00M 1648.00M 1841.00M
Ebitda 3106.00M 1962.00M 2466.00M 2340.00M 2624.00M
Depreciation and amortization 790.00M 710.00M 692.00M 692.00M 783.00M
Non operating income net other - - 4.00M -24.00M 31.00M
Operating income 2275.00M 1243.00M 727.00M 1648.00M 1841.00M
Other operating expenses 220303.00M 225584.00M 203242.00M 179700.00M 160673.00M
Interest expense 215.00M 51.00M 93.00M 149.00M 180.00M
Tax provision 532.00M 348.00M 376.00M 163.00M -289.00M
Interest income 215.00M 51.00M 93.00M 147.00M 182.00M
Net interest income -215.00M -51.00M -93.00M -149.00M -180.00M
Non recurring - - 1043.00M 2260.00M 1322.00M
Income tax expense 532.00M 348.00M 376.00M 163.00M -289.00M
Total revenue 222578.00M 226827.00M 205012.00M 181364.00M 162467.00M
Total operating expenses 5893.00M 6171.00M 5119.00M 4881.00M 4984.00M
Cost of revenue 214410.00M 219413.00M 198123.00M 174819.00M 155689.00M
Total other income expense net -174.00M -42.00M -1039.00M -2417.00M -1518.00M
Net income from continuing ops 1569.00M 853.00M 262.00M -932.00M 612.00M
Net income applicable to common shares 1561.00M 852.00M 261.00M -933.00M 611.00M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 53122.00M 45121.00M 43417.00M 43878.00M 44453.00M
Intangible assets 2486.00M 1725.00M 1472.00M 1774.00M 2105.00M
Other current assets 2426.00M 2710.00M 2362.00M 2021.00M 3944.00M
Total liab 55756.00M 48333.00M 46268.00M 44584.00M 42659.00M
Total stockholder equity -2781.00M -3213.00M -2851.00M -706.00M 1794.00M
Deferred long term liab - - 8653.00M 9299.00M 9670.00M
Other current liab 3470.00M 3447.00M 42.00M 2842.00M 96.00M
Common stock 2956.00M 2917.00M 2747.00M 2813.00M 2806.00M
Capital stock 2956.00M 2917.00M 2747.00M 2813.00M 2806.00M
Retained earnings 783.00M -286.00M -534.00M -280.00M 1205.00M
Other liab - - 8278.00M 9299.00M 9670.00M
Good will 9691.00M 4725.00M 4609.00M 5855.00M 7989.00M
Other assets 956.00M 783.00M 606.00M 953.00M 951.00M
Cash 3874.00M 5133.00M 4043.00M 4717.00M 3407.00M
Cash and equivalents 3874.00M 5133.00M 4043.00M 4717.00M 3407.00M
Total current liabilities 38897.00M 35640.00M 33706.00M 30550.00M 27624.00M
Current deferred revenue - - 3059.00M - 2957.00M
Net debt 5471.00M 476.00M 658.00M 598.00M 2829.00M
Short term debt 714.00M 551.00M 792.00M 580.00M 871.00M
Short long term debt 550.00M 434.00M 792.00M 580.00M 871.00M
Short long term debt total 9345.00M 5609.00M 4701.00M 5315.00M 6236.00M
Other stockholder equity -6365.00M -5677.00M -4913.00M -3125.00M -2183.00M
Property plant equipment 3616.00M 3004.00M 2462.00M 2361.00M 2360.00M
Total current assets 36373.00M 34884.00M 33833.00M 32935.00M 31048.00M
Net tangible assets - - -8933.00M -8338.00M -8300.00M
Short term investments - 200.00M - - -
Net receivables 13242.00M 12084.00M 11344.00M 10561.00M 9103.00M
Long term debt 7977.00M 4658.00M 3909.00M 4735.00M 5365.00M
Inventory 16831.00M 14957.00M 15940.00M 15636.00M 14594.00M
Accounts payable 34713.00M 31759.00M 29813.00M 27128.00M 23700.00M
Noncontrolling interest in consolidated entity - - 1.00M 3.00M 3.00M
Accumulated other comprehensive income -155.00M -167.00M -151.00M -114.00M -34.00M
Common stock total equity - - 2747.00M 2813.00M 2806.00M
Retained earnings total equity - - -534.00M -280.00M 1205.00M
Treasury stock - - -4914.00M -3128.00M -2186.00M
Non currrent assets other 1700.00M 1215.00M 1041.00M -8346.00M 951.00M
Non current assets total 16749.00M 10237.00M 9584.00M 10943.00M 13405.00M
Long term debt total 7977.00M 4658.00M 3909.00M 4735.00M 5365.00M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -5593.00M -1849.00M -454.00M 22.00M 25.00M
Change to liabilities - - 2718.00M 3428.00M 2325.00M
Total cashflows from investing activities -5605.00M -1849.00M -454.00M 567.00M -378.00M
Net borrowings 3224.00M 356.00M -579.00M -885.00M -570.00M
Total cash from financing activities 1952.00M -847.00M -3051.00M -2463.00M -1317.00M
Change to operating activities - - - 293.00M 452.00M
Net income 1569.00M 853.00M 262.00M -932.00M 612.00M
Change in cash -1259.00M 1057.00M -674.00M 1310.00M 636.00M
Begin period cash flow 5133.00M 4076.00M 4717.00M 3407.00M 2771.00M
End period cash flow 3874.00M 5133.00M 4043.00M 4717.00M 3407.00M
Total cash from operating activities 2397.00M 3762.00M 2839.00M 3122.00M 2429.00M
Depreciation 790.00M 710.00M 692.00M 692.00M 783.00M
Other cashflows from investing activities -10.00M 18.00M 2.00M 932.00M 22.00M
Dividends paid 494.00M 499.00M 525.00M 559.00M 573.00M
Change to inventory -1816.00M 1115.00M -340.00M -1071.00M -1584.00M
Change to account receivables -833.00M -996.00M -947.00M -1526.00M -904.00M
Sale purchase of stock -765.00M -750.00M -2000.00M -1000.00M -200.00M
Other cashflows from financing activities -13.00M 46.00M 53.00M -19.00M 26.00M
Change to netincome - - 1421.00M 2238.00M 746.00M
Capital expenditures 547.00M 511.00M 481.00M 387.00M 400.00M
Change receivables - - -947.00M -1526.00M -904.00M
Cash flows other operating - - -967.00M 293.00M 452.00M
Exchange rate changes - - - - 11.00M
Cash and cash equivalents changes - - -666.00M 1226.00M 745.00M
Change in working capital -523.00M 1510.00M 464.00M 1124.00M 289.00M
Stock based compensation 244.00M 121.00M 96.00M 81.00M 89.00M
Other non cash items 74.00M 672.00M 1356.00M 2150.00M 160.00M
Free cash flow 1850.00M 3251.00M 2358.00M 2735.00M 2029.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CAH
Cardinal Health Inc		 8.99
3.55%		 261.93 29.48 17.92 0.20 16.07 0.22 15.67
MCK
McKesson Corporation		 69.82
6.98%		 1069.44 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.		 13.60
3.99%		 354.10 24.22 16.39 0.19 20.41 0.21 13.72
HSIC
Henry Schein Inc		 -
-%		 88.24 25.89 15.08 0.72 3.14 1.00 13.43
SHTDY
SINOPHARM GROUP CO LTD ADR		 0.11
1.04%		 10.69 6.18 7.49 0.01 0.76 0.03 0.72

Profile*

Cardinal Health Inc

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

7000 Cardinal Place, Dublin, OH, United States, 43017

614 757 5000

https://www.cardinalhealth.com

53084

Name Title Year Born
Mr. Jason M. Hollar CEO & Director 1973
Ms. Jessica L. Mayer Chief Legal & Compliance Officer 1970
Mr. Stephen M. Mason Chief Exec. Officer of Medical Segment 1972
Ms. Patricia M. English Sr. VP & Interim CFO 1980
Ms. Mary C. Scherer Sr. VP & Chief Accounting Officer NA
Ms. Michelle Greene Exec. VP & Chief Information Officer and Global Bus. Services NA
Mr. Kevin Moran VP of Investor Relations NA
Ms. Ola M. Snow Chief HR Officer 1968
Mr. Craig Cowman Exec. VP of Strategic Sourcing & Manufacturer Services NA
Ms. Deborah L. Weitzman Chief Exec. Officer of Pharmaceutical Distribution NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…